FDA approves weight-loss drug Wegovy to reduce heart-disease risks
The U.S. Food and Drug administration approved the weight-loss drug Wegovy as a treatment to reduce cardiovascular risk in adults who are overweight, the first approval of its kind that could dramatically expand the already huge market for the drug. ... [1365 chars]
Source: The Washington Post
